{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:58:32Z","timestamp":1770883112115,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.prostaglandins.2009.07.006","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T08:47:21Z","timestamp":1250153241000},"page":"140-146","source":"Crossref","is-referenced-by-count":48,"title":["Evaluating dual activity LPA receptor pan-antagonist\/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors"],"prefix":"10.1016","volume":"89","author":[{"given":"Xiaoyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn D.","family":"Prestwich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2009.07.006_bib1","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1158\/0008-5472.CAN-05-3627","article-title":"Contributions of human tumor xenografts to anticancer drug development","volume":"66","author":"Sausville","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1089\/ten.2006.0297","article-title":"Tumor engineering: orthotopic cancer models in mice using cell-loaded, injectable, cross-linked hyaluronan-derived hydrogels","volume":"13","author":"Liu","year":"2007","journal-title":"Tissue Eng"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s11605-007-0425-3","article-title":"Synthetic extracellular matrix enhances tumor growth and metastasis in an orthotopic mouse model of pancreatic adenocarcinoma","volume":"12","author":"Scaife","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib4","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1158\/0008-5472.CAN-09-0302","article-title":"Dual activity lysophosphatidic acid receptor pan-antagonist\/autotaxin inhibitor suppresses breast cancer cell migration and invasion in vitro and causes tumor regression in vivo","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jcb.20113","article-title":"Lysophosphatidic acid production and action: validated targets in cancer?","volume":"92","author":"Umezu-Goto","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/138945008785132439","article-title":"Therapeutic potential of autotaxin\/lysophospholipase D inhibitors","volume":"9","author":"Federico","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","article-title":"Regulation and biological activities of the autotaxin-LPA axis","volume":"46","author":"van Meeteren","year":"2007","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1388-1981(02)00133-6","article-title":"Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids","volume":"1582","author":"Tokumura","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","article-title":"Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex","volume":"135","author":"Hecht","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D","article-title":"Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer","volume":"92","author":"Schulte","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1155\/2008\/857474","article-title":"GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung","volume":"24","author":"Gugger","year":"2008","journal-title":"Dis Mark"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bbalip.2008.03.008","article-title":"Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer","volume":"1781","author":"Prestwich","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/cmdc.200600280","article-title":"Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA","volume":"2","author":"Jiang","year":"2007","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib16","first-page":"2419","article-title":"Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model","volume":"17","author":"Wyrick","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/bi00350a005","article-title":"Basement membrane complexes with biological activity","volume":"25","author":"Kleinman","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/ar7000827","article-title":"Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery","volume":"41","author":"Prestwich","year":"2008","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib19","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1089\/ten.2006.12.2131","article-title":"Review Hyaluronan: a powerful tissue engineering tool","volume":"12","author":"Allison","year":"2006","journal-title":"Tissue Eng"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib20","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jcb.21386","article-title":"Simplifying the extracellular matrix for 3D cell culture and tissue engineering: a pragmatic approach","volume":"101","author":"Prestwich","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/org.6152","article-title":"Engineering a clinically useful matrix for cell therapy","volume":"4","author":"Prestwich","year":"2008","journal-title":"Organogenesis"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mabi.200800141","article-title":"Rheological properties of crosslinked hyaluronan-gelatin hydrogels for tissue engineering","volume":"9","author":"Vanderhooft","year":"2008","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ijc.21743","article-title":"Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors","volume":"119","author":"Sui","year":"2006","journal-title":"Int J Cancer"},{"issue":"Suppl. 10","key":"10.1016\/j.prostaglandins.2009.07.006_bib25","doi-asserted-by":"crossref","first-page":"x65","DOI":"10.1093\/annonc\/mdl239","article-title":"Angiogenesis: health and disease","volume":"17","author":"Bikfalvi","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib28","first-page":"216","article-title":"Tumour angiogenesis: ultrastructure of endothelial cells in mitosis","volume":"53","author":"Warren","year":"1972","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib29","first-page":"346","article-title":"Angiogenesis by capillary endothelial cells in culture","volume":"100","author":"Folkman","year":"1980","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/157489206775246502","article-title":"Intracellular calcium, endothelial cells and angiogenesis","volume":"1","author":"Munaron","year":"2006","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib32","first-page":"2159","article-title":"Angiogenesis-dependent tumor spread in reinforced fibrin clot culture","volume":"43","author":"Nicosia","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib33","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M301042200","article-title":"Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a)","volume":"278","author":"Kim","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib34","first-page":"89","article-title":"Tumor interactions with the vasculature: angiogenesis and tumor metastasis","volume":"1032","author":"Blood","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02484513","article-title":"Angiogenesis and antiangiogenic therapy for malignant gliomas","volume":"21","author":"Takano","year":"2004","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1215\/S115285170400119X","article-title":"Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy","volume":"7","author":"Rege","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4161\/cbt.4.8.2021","article-title":"Combination therapy with bacteria and angiogenesis inhibitors: strangling cancer without mercy","volume":"4","author":"Zhou","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib38","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.105.566497","article-title":"Cell therapy for angiogenesis: embracing diversity","volume":"112","author":"Gulati","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.cgt.7700428","article-title":"VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice","volume":"9","author":"Kamiyama","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nano.2005.03.008","article-title":"A review: integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis","volume":"1","author":"Lim","year":"2005","journal-title":"Nanomedicine"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1024\/0301-1526.36.4.253","article-title":"Therapeutic angiogenesis for peripheral artery disease: cytokine therapy","volume":"36","author":"Kuhlmann","year":"2007","journal-title":"Vasa"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib42","first-page":"804","article-title":"Extracellular matrix-cell interactions: Matrigel and complex cellular pattern formation","volume":"67","author":"Passaniti","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib43","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.biomaterials.2005.03.012","article-title":"Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor","volume":"26","author":"Cai","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib44","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.biomaterials.2008.01.033","article-title":"Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels","volume":"29","author":"Hosack","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib45","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1073\/pnas.91.5.1908","article-title":"Lysophosphatidic acid possesses dual action in cell proliferation","volume":"91","author":"Tigyi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.20.4.1013","article-title":"Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration","volume":"20","author":"Panetti","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/excr.1995.1007","article-title":"Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin","volume":"216","author":"Piazza","year":"1995","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib48","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.4049\/jimmunol.162.4.2049","article-title":"Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax","volume":"162","author":"Goetzl","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib49","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cellsig.2008.06.008","article-title":"Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1\/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms","volume":"20","author":"Lin","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10456-008-9113-5","article-title":"Lysophosphatidic acid (LPA) and angiogenesis","volume":"11","author":"Rivera-Lopez","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib51","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","article-title":"Sunitinib: from rational design to clinical efficacy","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib53","first-page":"5132","article-title":"Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice","volume":"47","author":"McLemore","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ijc.2910280617","article-title":"Heterotransplantation of small-cell carcinoma of the lung into nude mice: comparison of intracranial and subcutaneous routes","volume":"28","author":"Gazdar","year":"1981","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib55","unstructured":"Xu X, Prestwich GD, Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in a engineered three-dimensional lung cancer xenograft model. Cancer; in press."},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11912-008-0043-6","article-title":"Hypoxia angiogenesis, and lung cancer","volume":"10","author":"Goudar","year":"2008","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib57","first-page":"525","article-title":"Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts","volume":"33","author":"Sasaki","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib58","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1541-7786.MCR-06-0338","article-title":"Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A-549 lung carcinoma cells","volume":"5","author":"Murph","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib59","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23044","article-title":"Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives","volume":"110","author":"Espey","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib60","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1002\/1097-0142(19930615)71:12+<4252::AID-CNCR2820711815>3.0.CO;2-6","article-title":"Surgical treatment of liver metastases in patients with colorectal cancer","volume":"71","author":"Ballantyne","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3322\/canjclin.57.3.168","article-title":"Adjuvant treatment of colorectal cancer","volume":"57","author":"Wolpin","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib62","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(19840115)53:2<360::AID-CNCR2820530232>3.0.CO;2-U","article-title":"Adenocarcinoma of the proximal colon sites of initial dissemination and patterns of recurrence following surgery alone","volume":"53","author":"Russell","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/sonc.2002.31680","article-title":"Intrahepatic arterial infusion of chemotherapy: clinical results","volume":"29","author":"Dizon","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib64","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archsurg.1989.01410090027004","article-title":"Hepatic resection for metastases from colorectal carcinoma is of dubious value","volume":"124","author":"Silen","year":"1989","journal-title":"Arch Surg"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib65","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1073\/pnas.0501535102","article-title":"G-protein coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the beta-catenin pathway","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib66","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1152\/ajpcell.00610.2004","article-title":"LPA2 receptor mediates mitogenic signals in human colon cancer cells","volume":"289","author":"Yun","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00280-008-0720-z","article-title":"Antitumor activity of noscapine in human non-small cell lung cancer xenograft model","volume":"63","author":"Jackson","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib68","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0204183","volume":"46","author":"Sun","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.prostaglandins.2009.07.006_bib69","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882309000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882309000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:39:27Z","timestamp":1685093967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882309000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":69,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1098882309000537"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2009.07.006","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}